Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
Tao YL, Wu DH, Zhou Q, Yang KY, Jin F, Zhu XD, Shi M, Hu GQ, Sun Y, Wu HF, Wu H, Lin Q, Wang H, Tian Y, Zhang N, Wang XC, Shen LF, Liu ZZ, Huang J, Luo XL, Li L, Zang J, Mei Q, Zheng BM, Yue D, Xu J, Wu SG, Chen L, Li WF, Zhou GQ, Sun R, Guo R, Zhang Y, Xu C, Lv JW, Guo Y, Feng HX, Tang LL, Xie FY, Liu X, Sun Y, Ma J, Mao YP, Chen YP.
Tao YL, et al. Among authors: chen yp.
Nat Cancer. 2026 Jun 30. doi: 10.1038/s43018-026-01193-4. Online ahead of print.
Nat Cancer. 2026.
PMID: 42380630